Literature DB >> 27411684

Measles.

Paul A Rota1, William J Moss2, Makoto Takeda3, Rik L de Swart4, Kimberly M Thompson5,6, James L Goodson1.   

Abstract

Measles is an infectious disease in humans caused by the measles virus (MeV). Before the introduction of an effective measles vaccine, virtually everyone experienced measles during childhood. Symptoms of measles include fever and maculopapular skin rash accompanied by cough, coryza and/or conjunctivitis. MeV causes immunosuppression, and severe sequelae of measles include pneumonia, gastroenteritis, blindness, measles inclusion body encephalitis and subacute sclerosing panencephalitis. Case confirmation depends on clinical presentation and results of laboratory tests, including the detection of anti-MeV IgM antibodies and/or viral RNA. All current measles vaccines contain a live attenuated strain of MeV, and great progress has been made to increase global vaccination coverage to drive down the incidence of measles. However, endemic transmission continues in many parts of the world. Measles remains a considerable cause of childhood mortality worldwide, with estimates that >100,000 fatal cases occur each year. Case fatality ratio estimates vary from <0.01% in industrialized countries to >5% in developing countries. All six WHO regions have set goals to eliminate endemic transmission of MeV by achieving and maintaining high levels of vaccination coverage accompanied by a sensitive surveillance system. Because of the availability of a highly effective and relatively inexpensive vaccine, the monotypic nature of the virus and the lack of an animal reservoir, measles is considered a candidate for eradication.

Entities:  

Mesh:

Year:  2016        PMID: 27411684     DOI: 10.1038/nrdp.2016.49

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  71 in total

Review 1.  Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.

Authors:  Stephen J Russell; Dusica Babovic-Vuksanovic; Alice Bexon; Roberto Cattaneo; David Dingli; Angela Dispenzieri; David R Deyle; Mark J Federspiel; Adele Fielding; Eva Galanis; Martha Q Lacy; Bradley C Leibovich; Minetta C Liu; Miguel Muñoz-Alía; Tanner C Miest; Julian R Molina; Sabine Mueller; Scott H Okuno; Nandakumar Packiriswamy; Tobias Peikert; Corey Raffel; Frits Van Rhee; Guy Ungerechts; Paul R Young; Yumei Zhou; Kah-Whye Peng
Journal:  Mayo Clin Proc       Date:  2019-06-22       Impact factor: 7.616

2.  Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study.

Authors:  Lixin Hao; John W Glasser; Qiru Su; Chao Ma; Zhilan Feng; Zundong Yin; James L Goodson; Ning Wen; Chunxiang Fan; Hong Yang; Lance E Rodewald; Zijian Feng; Huaqing Wang
Journal:  Int J Epidemiol       Date:  2019-08-01       Impact factor: 7.196

3.  Controversies' clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages.

Authors:  George D Liatsos
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

4.  The Brief Case: Secondary Measles and the Pitfalls of Diagnostic Testing.

Authors:  Marwan M Azar; Joseph Canterino; Marie L Landry
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

5.  Progress towards Rapid Detection of Measles Vaccine Strains: a Tool To Inform Public Health Interventions.

Authors:  Jill K Hacker
Journal:  J Clin Microbiol       Date:  2016-12-21       Impact factor: 5.948

6.  Genotype-Specific Measles Transmissibility: A Branching Process Analysis.

Authors:  Sarah F Ackley; Jill K Hacker; Wayne T A Enanoria; Lee Worden; Seth Blumberg; Travis C Porco; Jennifer Zipprich
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

7.  Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.

Authors:  Guillaume B E Stewart-Jones; Gwo-Yu Chuang; Kai Xu; Tongqing Zhou; Priyamvada Acharya; Yaroslav Tsybovsky; Li Ou; Baoshan Zhang; Blanca Fernandez-Rodriguez; Valentina Gilardi; Chiara Silacci-Fregni; Martina Beltramello; Ulrich Baxa; Aliaksandr Druz; Wing-Pui Kong; Paul V Thomas; Yongping Yang; Kathryn E Foulds; John-Paul Todd; Hui Wei; Andres M Salazar; Diana G Scorpio; Bridget Carragher; Clinton S Potter; Davide Corti; John R Mascola; Antonio Lanzavecchia; Peter D Kwong
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-12       Impact factor: 11.205

8.  Measles vaccine immune escape: Should we be concerned?

Authors:  Luojun Yang; Bryan T Grenfell; Michael J Mina
Journal:  Eur J Epidemiol       Date:  2019-11-01       Impact factor: 8.082

Review 9.  Receptor-mediated cell entry of paramyxoviruses: Mechanisms, and consequences for tropism and pathogenesis.

Authors:  Chanakha K Navaratnarajah; Alex R Generous; Iris Yousaf; Roberto Cattaneo
Journal:  J Biol Chem       Date:  2020-01-16       Impact factor: 5.157

10.  A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.

Authors:  Jessica C Joyce; Timothy D Carroll; Marcus L Collins; Min-Hsin Chen; Linda Fritts; Joseph C Dutra; Tracy L Rourke; James L Goodson; Michael B McChesney; Mark R Prausnitz; Paul A Rota
Journal:  J Infect Dis       Date:  2018-06-05       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.